SK286397B6 - 2-Halogén-6-O-substituované ketolidové deriváty, ich použitie, spôsob ich prípravy a farmaceutické kompozície s ich obsahom - Google Patents

2-Halogén-6-O-substituované ketolidové deriváty, ich použitie, spôsob ich prípravy a farmaceutické kompozície s ich obsahom Download PDF

Info

Publication number
SK286397B6
SK286397B6 SK633-2000A SK6332000A SK286397B6 SK 286397 B6 SK286397 B6 SK 286397B6 SK 6332000 A SK6332000 A SK 6332000A SK 286397 B6 SK286397 B6 SK 286397B6
Authority
SK
Slovakia
Prior art keywords
formula
compound
quinolyl
compounds
group
Prior art date
Application number
SK633-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK6332000A3 (en
Inventor
Ly Tam Phan
Yat Sun Or
Daniel T. Chu
Jacob J. Plattner
Yan Chen
Richard F. Clark
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of SK6332000A3 publication Critical patent/SK6332000A3/sk
Publication of SK286397B6 publication Critical patent/SK286397B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
SK633-2000A 1997-10-29 1998-10-29 2-Halogén-6-O-substituované ketolidové deriváty, ich použitie, spôsob ich prípravy a farmaceutické kompozície s ich obsahom SK286397B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95988197A 1997-10-29 1997-10-29
US15423998A 1998-09-16 1998-09-16
PCT/US1998/022989 WO1999021871A1 (en) 1997-10-29 1998-10-29 2-halo-6-o-substituted ketolide derivatives

Publications (2)

Publication Number Publication Date
SK6332000A3 SK6332000A3 (en) 2000-09-12
SK286397B6 true SK286397B6 (sk) 2008-09-05

Family

ID=26851273

Family Applications (1)

Application Number Title Priority Date Filing Date
SK633-2000A SK286397B6 (sk) 1997-10-29 1998-10-29 2-Halogén-6-O-substituované ketolidové deriváty, ich použitie, spôsob ich prípravy a farmaceutické kompozície s ich obsahom

Country Status (25)

Country Link
EP (1) EP1027362B1 (ja)
JP (1) JP2001521039A (ja)
KR (1) KR100536420B1 (ja)
CN (1) CN1240707C (ja)
AR (1) AR015994A1 (ja)
AT (1) ATE298760T1 (ja)
AU (1) AU751448B2 (ja)
BG (1) BG64707B1 (ja)
BR (1) BR9813319A (ja)
CA (1) CA2307788C (ja)
CO (1) CO4990960A1 (ja)
CZ (1) CZ300063B6 (ja)
DE (1) DE69830739T2 (ja)
DK (1) DK1027362T3 (ja)
ES (1) ES2244094T3 (ja)
HK (1) HK1031383A1 (ja)
HU (1) HUP0004282A3 (ja)
IL (1) IL135519A0 (ja)
NO (1) NO20002190L (ja)
NZ (1) NZ503822A (ja)
PL (1) PL191453B1 (ja)
PT (1) PT1027362E (ja)
SK (1) SK286397B6 (ja)
TR (1) TR200001142T2 (ja)
WO (1) WO1999021871A1 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784682B1 (fr) 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
USRE39743E1 (en) * 1998-10-15 2007-07-24 Aventis Pharma S.A. 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
DE60030847T2 (de) 1999-04-16 2007-04-19 Kosan Biosciences, Inc., Hayward Antiinfektiöse makrolidderivate
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
ATE397615T1 (de) * 1999-12-02 2008-06-15 Abbott Lab 6-o-alkyl-2-nor-2-substituierte ketolidderivate
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
JP2001261694A (ja) * 2000-03-06 2001-09-26 Pfizer Prod Inc ケトライド抗生物質
US6605707B1 (en) * 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
DK1167376T3 (da) 2000-06-30 2004-10-25 Pfizer Prod Inc Makrolidantibiotika
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CA2460947A1 (en) 2001-09-17 2003-03-27 Ortho-Mcneil Pharmaceutical, Inc. 6-o-carbamate-11,12-lacto-ketolide antimicrobials
WO2003050132A1 (en) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
MXPA04007883A (es) * 2002-02-13 2004-11-26 Abbott Lab Compuestos antimicrobianos de macrolido.
WO2003090760A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories Oxolide antibacterials
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
JPWO2004078771A1 (ja) * 2003-03-07 2006-06-08 大正製薬株式会社 ２−フルオロ−６−ｏ−置換ケトライド誘導体
JP2007254285A (ja) * 2004-03-16 2007-10-04 Taisho Pharmaceut Co Ltd ２−フルオロ−６−ｏ−置換ケトライド誘導体
CA2763246C (en) * 2009-05-27 2013-10-29 Wockhardt Research Centre Ketolide compounds having antimicrobial activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
DK0638584T3 (da) * 1992-04-22 1996-04-15 Taisho Pharmaceutical Co Ltd 5-O-desosaminyl-erythronolid-A-derivat
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
NO20002190D0 (no) 2000-04-27
PL191453B1 (pl) 2006-05-31
KR20010015793A (ko) 2001-02-26
JP2001521039A (ja) 2001-11-06
CZ300063B6 (cs) 2009-01-21
CN1283199A (zh) 2001-02-07
ATE298760T1 (de) 2005-07-15
DE69830739T2 (de) 2006-04-20
KR100536420B1 (ko) 2005-12-16
CA2307788C (en) 2008-05-20
PL340290A1 (en) 2001-01-29
EP1027362B1 (en) 2005-06-29
AU751448B2 (en) 2002-08-15
SK6332000A3 (en) 2000-09-12
CZ20001525A3 (cs) 2000-10-11
NZ503822A (en) 2002-12-20
AR015994A1 (es) 2001-05-30
CO4990960A1 (es) 2000-12-26
BR9813319A (pt) 2000-08-22
HUP0004282A2 (hu) 2001-04-28
PT1027362E (pt) 2005-08-31
EP1027362A1 (en) 2000-08-16
BG64707B1 (bg) 2005-12-30
AU1288199A (en) 1999-05-17
CA2307788A1 (en) 1999-05-06
DE69830739D1 (de) 2005-08-04
BG104434A (en) 2001-01-31
WO1999021871A1 (en) 1999-05-06
ES2244094T3 (es) 2005-12-01
DK1027362T3 (da) 2005-10-31
NO20002190L (no) 2000-06-29
IL135519A0 (en) 2001-05-20
CN1240707C (zh) 2006-02-08
TR200001142T2 (tr) 2000-09-21
HUP0004282A3 (en) 2001-10-29
HK1031383A1 (en) 2001-06-15

Similar Documents

Publication Publication Date Title
US6124269A (en) 2-Halo-6-O-substituted ketolide derivatives
SK286397B6 (sk) 2-Halogén-6-O-substituované ketolidové deriváty, ich použitie, spôsob ich prípravy a farmaceutické kompozície s ich obsahom
CA2372270C (en) C-2 modified erythromycin derivatives
EP1015467B1 (en) 6,9-bridged erythromycin derivatives
EP1161438B1 (en) 6-o-substituted macrolides having antibacterial activity
SK4562000A3 (en) 3'-N-MODIFIED 6-O-SUBSTITUTED ERYTHROMYCIN KETOLIDE DERIVATIVESì (54) HAVING ANTIBACTERIAL ACTIVITY
AU1286799A (en) 6,11-bridged erythromycin derivatives
US6034069A (en) 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US20020019355A1 (en) Anti-infective agents useful against multidrug-resistant strains of bacteria
US6569836B2 (en) 6-O-alkyl-2-nor-2-substituted ketolide derivatives
JP2003501439A5 (ja)
CA2391297C (en) 6-o-alkyl-2-nor-2-substituted ketolide derivatives
JP2001518475A (ja) 環状亜リン酸およびリン酸塩
JP4025548B2 (ja) 多薬剤耐性菌株に対して有用な抗感染症薬
JP4368950B2 (ja) 多環式エリスロマイシン誘導体
MXPA00004226A (es) Derivados de ketólido 2-halo-6-o-substituidos
CZ2000811A3 (cs) 6,9-můstkové erythromycinové deriváty a způsob jejich přípravy
CZ20001045A3 (cs) 3-N-módilikováné 6-O-substituované ketolidové deriváty erytromycinu
CZ407399A3 (cs) Multicyklické deriváty erythromycinu

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20101029